Robinson LabOur lab studies the molecular mechanisms of
and develops therapies to treat autoimmune disease, with a focus on rheumatoid
arthritis (RA) and multiple sclerosis (MS).
The overriding objectives of our laboratory include:
- To investigate the mechanisms mediating autoimmune disease.
- To study the mechanisms underlying immune
tolerance.
- To develop specific therapies for the treatment of autoimmune disease.
We perform translational bench-to-bedside research, with the goal
of rapidly converting discoveries at the bench into practical patient
care tools and therapies.
We are part of the Division
of Immunology and Rheumatology in the Department
of Medicine, the Program in
Immunology,
and the Center for Clinical Immunology
at Stanford (CCIS), at Stanford
University School of Medicine. We are also part of the GRECC at
the Palo
Alto VA Health Care System, and the Institute
for Immunity Transplantation and Infection (ITI) at Stanford.
|
